233 related articles for article (PubMed ID: 30485605)
21. Study of cohort-specific consent and patient control in phase I cancer trials.
Daugherty CK; Ratain MJ; Minami H; Banik DM; Vogelzang NJ; Stadler WM; Siegler M
J Clin Oncol; 1998 Jul; 16(7):2305-12. PubMed ID: 9667244
[TBL] [Abstract][Full Text] [Related]
22. Patients' reasoning regarding the decision to participate in clinical cancer trials: an interview study.
Dellson P; Nilsson K; Jernström H; Carlsson C
Trials; 2018 Sep; 19(1):528. PubMed ID: 30268150
[TBL] [Abstract][Full Text] [Related]
23. "Tell me what you suggest, and let's do that, doctor": Patient deliberation time during informal decision-making in clinical trials.
Nakada H; Yoshida S; Muto K
PLoS One; 2019; 14(1):e0211338. PubMed ID: 30695047
[TBL] [Abstract][Full Text] [Related]
24. Trusting relationships between patients with non-curative cancer and healthcare professionals create ethical obstacles for informed consent in clinical trials: a grounded theory study.
Murphy M; McCaughan E; Thompson G; Carson MA; Hanna JR; Donovan M; Wilson RH; Fitzsimons D
BMC Palliat Care; 2023 Jul; 22(1):85. PubMed ID: 37393250
[TBL] [Abstract][Full Text] [Related]
25. A systematic review of risk communication in clinical trials: How does it influence decisions to participate and what are the best methods to improve understanding in a trial context?
Coyle M; Gillies K
PLoS One; 2020; 15(11):e0242239. PubMed ID: 33196663
[TBL] [Abstract][Full Text] [Related]
26. Decision Aids Can Support Cancer Clinical Trials Decisions: Results of a Randomized Trial.
Politi MC; Kuzemchak MD; Kaphingst KA; Perkins H; Liu J; Byrne MM
Oncologist; 2016 Dec; 21(12):1461-1470. PubMed ID: 27511904
[TBL] [Abstract][Full Text] [Related]
27. Development of a tool to assess the completeness of drug information sources for health care professionals: A Delphi study.
Arguello B; Salgado TM; Laekeman G; Fernandez-Llimos F
Regul Toxicol Pharmacol; 2017 Nov; 90():87-94. PubMed ID: 28842337
[TBL] [Abstract][Full Text] [Related]
28. What do people with knee or hip osteoarthritis need to know? An international consensus list of essential statements for osteoarthritis.
French SD; Bennell KL; Nicolson PJ; Hodges PW; Dobson FL; Hinman RS
Arthritis Care Res (Hoboken); 2015 May; 67(6):809-16. PubMed ID: 25418120
[TBL] [Abstract][Full Text] [Related]
29. [Information provided in writing for "informed consent" in clinical trials].
Sella A
Harefuah; 1999 May; 136(9):669-72, 756. PubMed ID: 10955084
[TBL] [Abstract][Full Text] [Related]
30. Development and evaluation of decision aids for people considering taking part in a clinical trial: a conceptual framework.
Gillies K; Campbell MK
Trials; 2019 Jul; 20(1):401. PubMed ID: 31277693
[TBL] [Abstract][Full Text] [Related]
31. Home therapy for inherited bleeding disorders in South Africa: Results of a modified Delphi consensus process.
Mahlangu JN; Naidoo Y; Goga Y; Vaithlingum M; Joubert J; Sutton C; Potgieter J; Cruickshank AL; Iorio A
S Afr Med J; 2019 Aug; 109(9):639-644. PubMed ID: 31635587
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer.
Hutchison C; Campbell S
Eur J Cancer Care (Engl); 2002 Jun; 11(2):131-8. PubMed ID: 12099949
[TBL] [Abstract][Full Text] [Related]
33. Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.
Tomamichel M; Sessa C; Herzig S; de Jong J; Pagani O; Willems Y; Cavalli F
Ann Oncol; 1995 Apr; 6(4):363-9. PubMed ID: 7619751
[TBL] [Abstract][Full Text] [Related]
34. Supporting informed clinical trial decisions: Results from a randomized controlled trial evaluating a digital decision support tool for those with intellectual disability.
McCormack LA; Wylie A; Moultrie R; Furberg RD; Wheeler AC; Treiman K; Bailey DB; Raspa M
PLoS One; 2019; 14(10):e0223801. PubMed ID: 31644588
[TBL] [Abstract][Full Text] [Related]
35. The Experience of Surrogate Decision Makers on Being Approached for Consent for Patient Participation in Research. A Multicenter Study.
Burns KE; Prats CJ; Maione M; Lanceta M; Zubrinich C; Jeffs L; Smith OM;
Ann Am Thorac Soc; 2017 Feb; 14(2):238-245. PubMed ID: 27849142
[TBL] [Abstract][Full Text] [Related]
36. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
Vanderpool HY
Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
[TBL] [Abstract][Full Text] [Related]
37. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness.
Gobat NH; Gal M; Francis NA; Hood K; Watkins A; Turner J; Moore R; Webb SA; Butler CC; Nichol A
Trials; 2015 Dec; 16():591. PubMed ID: 26715077
[TBL] [Abstract][Full Text] [Related]
38. Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
Schlessinger DI; Iyengar S; Yanes AF; Lazaroff JM; Godinez-Puig V; Chen BR; Kurta AO; Henley JK; Chiren SG; Furlan KC; Schmitt J; Deckert S; Poon E; Sobanko JF; Cartee TV; Alam M; Maher IA
Trials; 2017 Oct; 18(1):490. PubMed ID: 29061190
[TBL] [Abstract][Full Text] [Related]
39. Core information sets for informed consent to surgical interventions: baseline information of importance to patients and clinicians.
Main BG; McNair AGK; Huxtable R; Donovan JL; Thomas SJ; Kinnersley P; Blazeby JM
BMC Med Ethics; 2017 Apr; 18(1):29. PubMed ID: 28446164
[TBL] [Abstract][Full Text] [Related]
40. Comparing two methods for delivering clinical trial informed consent information to older adults: singular versus stepped approach.
O'Hare F; Flanagan Z; Nelson M; Curtis A; Heritier S; Spark S; Zoungas S
Clin Trials; 2018 Dec; 15(6):610-615. PubMed ID: 30074410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
